Rachel K. King
2021
In 2021, Rachel K. King earned a total compensation of $1.4M as Former President and Chief Executive Officer at GlycoMimetics, a 40% decrease compared to previous year.
Compensation breakdown
| Option Awards | $520,955 |
|---|---|
| Salary | $511,146 |
| Stock Awards | $366,713 |
| Other | $22,034 |
| Total | $1,420,848 |
King received $521K in option awards, accounting for 37% of the total pay in 2021.
King also received $511.1K in salary, $366.7K in stock awards and $22K in other compensation.
Rankings
In 2021, Rachel K. King's compensation ranked 7,478th out of 12,415 executives tracked by ExecPay. In other words, King earned more than 39.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,478 out of 12,415 | 40th |
Division Manufacturing | 3,291 out of 5,505 | 40th |
Major group Chemicals And Allied Products | 1,457 out of 2,375 | 39th |
Industry group Drugs | 1,298 out of 2,096 | 38th |
Industry Pharmaceutical Preparations | 955 out of 1,546 | 38th |
Source: SEC filing on April 11, 2022.
King's colleagues
We found three more compensation records of executives who worked with Rachel K. King at GlycoMimetics in 2021.